Investor’s Watch List: ReShape Lifesciences Inc. (NASDAQ:RSLS), TherapeuticsMD, Inc. (NASDAQ:TXMD)


ReShape Lifesciences Inc. (NASDAQ:RSLS)

ReShape Lifesciences Inc. (NASDAQ:RSLS) represented a move of -4.05 percent or $0.04 per share and closed its previous day trading session at $0.83. 806591 Shares were traded in the last trading session with an Average Volume of 1.05 Million Shares. The stock currently has a Market Capitalization of 480000.

ReShape Lifesciences Inc. is a developer of invasive medical devices to treat obesity and metabolic diseases. The company’s portfolio includes vBloc System(R), ReShape(R) and Gastric Vest System (TM). ReShape Lifesciences Inc., formerly known as EnteroMedics Inc., is based in CA, United States.

The stock traded between $0 / 0.800 and $3,759.000 over 1-Year time period showing its price to sales ratio of 0.18. ReShape Lifesciences Inc. (NASDAQ:RSLS) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.

Right now, the stock has a 50-Day Simple Moving Average of $-75.88 and 200-Day Simple Moving Average of $-99.89. Its Price to Free Cash Flow is 0 and Price to Book of 0.01.

Analyst’s recommended the stock as 3 where 1 represents Strong Buy and 5 represents Sell.

In the last Quarter, ReShape Lifesciences Inc. (NASDAQ:RSLS) reported its Actual EPS of $-672/share. The analysts offering Earnings Estimates for the company were believing that ReShape Lifesciences Inc. could bring EPS of $-250.6/share. The difference between Actual EPS and Estimated EPS was -421.4 Percent. Thus showing an Earnings Surprise of -168.2 Percent.

TherapeuticsMD, Inc. (NASDAQ:TXMD)

In the last trading session, TherapeuticsMD, Inc. (NASDAQ:TXMD) added its value by 1.99% closing at the price of $5.13. The stock currently has market capitalization of 1.21 Billion, with average volume of 2.88 Million shares.

Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently TherapeuticsMD, Inc. (NASDAQ:TXMD) is showing beta of 1.33. This particular value of beta suggests that TherapeuticsMD, Inc. (NASDAQ:TXMD) has historically moved 133% for every 100% move in the benchmark, based on price level.

EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for TherapeuticsMD, Inc. (NASDAQ:TXMD) is at $-0.52.

The stock currently has RSI of 52.53. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.

TherapeuticsMD, Inc. is a specialty pharmaceutical company focused on creating branded prescription, generic prescription and over-the-counter products targeted exclusively for women. It is developing three advanced hormone replacement products designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies. TherapeuticsMD, Inc. is based in Boca Raton, Florida.

TherapeuticsMD, Inc. (NASDAQ:TXMD) topped its 52-week high price of $7.66 on 06/08/18 and 52-Week Low Price of $4.30 on 10/30/18. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 4.54% and monthly volatility of 5.91% respectively.